Ultracef - Cefadroxil

Cefaclor (Ceclor, Ceclor CD) Cefadroxil (Duricef, Ultracef)... 

Cephradine Cephalexin Cefadroxil Velosef Keflex, Others Ultracef, Duricef PO Skin and soft tissue infections urinary tract infections... 

Cefadroxil (also sometimes spelled cephadroxil), an antibiotic originally developed by Bristol-Myers (BM) and marketed under the trade names Ultracef and Duricef, had combined sales in the US of 100 million in 1988. A crystalline monohydrate (apparently discovered serendipitously), claimed in U.S. Patent No. 4,504,657 (the 657 patent) issued in March 1985, is described in the patent in terms of its X-ray diffraction pattern (Fig. 10.2). The improvement of this substance over the earlier known material included greater stability and high bulk density, properties which enabled the production of smaller pills. 

Baxan Baxan Kapsein Bidocef Bidocel BL-S 578 Cefa-Drops Cefadroxil Cefadroxil monohydrate Cefamox Ceforal Cefos Granulat Cephos Duracef Duricef Kefroxil Kefroxil Kapsein MJF 11567-3 Moxacef Kapsein, Omnidrox Kapsein, Oracefal Sedral Ultracef. Antibacterial. A semisynthetic cephalosporin antibiotic intended for oral admin-isiration. It is a white to yellowish-white crystalline powder. It is soluble in water and it is acid-stable. Powder, mp = 197° (dec). Bristol-Myers Squibb Pharm. R D Mead Johnson Labs. 

---